研究报告

通过时间基因表达谱分析探究异烟肼引起肝损伤的机制

展开
  • 上海交通大学Bio-X研究院,上海 200030
田子钊,在读硕士研究生,专业方向:生物学。E-mail: tianzizhao@sjtu.edu.cn

收稿日期: 2022-03-10

  修回日期: 2022-04-26

  网络出版日期: 2022-05-11

基金资助

国家自然科学基金项目资助编号(81773818);国家自然科学基金项目资助编号(82003856)

Analysis of time-series gene expression data to explore mechanisms of isoniazid-induced liver toxicity

Expand
  • Bio-X Institute, Shanghai Jiaotong University, Shanghai 200030, China

Received date: 2022-03-10

  Revised date: 2022-04-26

  Online published: 2022-05-11

Supported by

Supported by the National Nature Science Foundation of China Nos(81773818);Supported by the National Nature Science Foundation of China Nos(82003856)

摘要

抗结核药物异烟肼具有肝脏毒性,其发生机制需要进一步阐明。本研究使用异烟肼处理肝细胞,分析不同处理时间表达谱的差异。通过对差异表达基因进行聚类分析和功能富集分析,共得到6个与肝脏毒性相关的基因簇和一系列相关通路;进一步通过蛋白互作分析和时间序列差异分析方法,筛选出表达水平具有时间依赖性的13个关键基因。本研究结果为理解异烟肼引发肝脏毒性过程提供了思路,为今后药物性肝脏毒性的监测以及治疗提供了新的靶基因。

本文引用格式

田子钊, 周晨希, 周伟, 李沫, 褚云鹏, 怀聪, 秦胜营 . 通过时间基因表达谱分析探究异烟肼引起肝损伤的机制[J]. 遗传, 2022 , 44(6) : 501 -509 . DOI: 10.16288/j.yczz.22-069

Abstract

Isoniazid (INH) is a first-line anti-tuberculosis drug which can cause idiosyncratic liver injury, while the underlying mechanisms need to be further elucidated. In this study, we explored the time series gene expression profiling of a hepatocyte cell line under isoniazid treatment. Through cluster analysis and enrichment analysis of differentially expressed genes, we revealed a total of 6 gene clusters and a series of pathways related to hepatotoxicity, and 13 key candidate genes were identified according to the protein-protein interaction (PPI) network analysis and maSigPro analysis. These findings lay a foundation for understanding the mechanisms of isoniazid -induced liver toxicity and provide new target genes for the monitoring and treatment of INH-induced hepatotoxicity in the future.

参考文献

[1] Schito M, Migliori GB, Fletcher HA, McNerney R,Centis R,D'Ambrosio L,Bates M,Kibiki G,Kapata N,Corrah T,Bomanji J,Vilaplana C,Johnson D,Mwaba P,Maeurer M,Zumla A,. Perspectives on advances in tuberculosis diagnostics, drugs, and vaccines. Clin Infect Dis, 2015, 61(Suppl 3):S102-S118.
[2] World Health Organization. Global tuberculosis report. 2021.
[3] Zhang Y, Cen J, Jia ZL, Hsiao CD, Xia Q, Wang X, Chen XQ, Wang RC, Jiang ZZ, Zhang LY, Liu KC. Hepatotoxicity induced by isoniazid-lipopolysaccharide through endoplasmic reticulum stress, autophagy, and apoptosis pathways in zebrafish. Antimicrob Agents Chemother, 2019, 63(5):e01639-18.
[4] Lee KK, Fujimoto K, Zhang C, Schwall CT, Alder NN, Pinkert CA, Krueger W, Rasmussen T, Boelsterli UA. Isoniazid-induced cell death is precipitated by underlying mitochondrial complex I dysfunction in mouse hepatocytes. Free Radic Biol Med, 2013, 65:584-594.
[5] Wang PC, Pradhan K, Zhong XB, Ma XC. Isoniazid metabolism and hepatotoxicity. Acta Pharm Sin B, 2016, 6(5):384-392.
[6] Metushi IG, Cai P, Zhu X, Nakagawa T, Uetrecht JP. A fresh look at the mechanism of isoniazid-induced hepatotoxicity. Clin Pharmacol Ther, 2011, 89(6):911-914.
[7] Huang YS. Recent progress in genetic variation and risk of antituberculosis drug-induced liver injury. J Chin Med Assoc, 2014, 77(4):169-173.
[8] Metushi I, Uetrecht J, Phillips E. Mechanism of isoniazid- induced hepatotoxicity: then and now. Br J Clin Pharmacol, 2016, 81(6):1030-1036.
[9] Huang YS, Chern HD, Su WJ, Wu JC, Lai SL, Yang SY, Chang FY, Lee SD. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology, 2002, 35(4):883-889.
[10] Ng CS, Hasnat A, Maruf AA, Ahmed MU, Pirmohamed M, Day CP, Aithal GP, Daly AK. N-acetyltransferase 2 (NAT2) genotype as a risk factor for development of drug-induced liver injury relating to antituberculosis drug treatment in a mixed-ethnicity patient group. Eur J Clin Pharmacol, 2014, 70(9):1079-1086.
[11] Huang YS, Chern HD, Su WJ, Wu JC, Chang SC, Chiang CH, Chang FY, Lee SD. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis. Hepatology, 2003, 37(4):924-930.
[12] Chen YS, Lun ATL, Smyth GK. From reads to genes to pathways: differential expression analysis of RNA-Seq experiments using Rsubread and the edgeR quasi-likelihood pipeline. F1000Res, 2016, 5:1438.
[13] Zhou GY, Soufan O, Ewald J, Hancock REW, Basu N, Xia JG. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res, 2019, 47(W1):W234-W241.
[14] Chen T, Liu YX, Huang LQ. ImageGP: An easy-to-use data visualization web server for scientific researchers. iMeta, 2022, 1(1):e5.
[15] Kumar L, Futschik ME. Mfuzz: A software package for soft clustering of microarray data. Bioinformation, 2007, 2(1):5-7.
[16] Futschik ME, Carlisle B. Noise-robust soft clustering of gene expression time-course data. J Bioinform Comput Biol, 2005, 3(4):965-988.
[17] Zhou YY, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK. Metascape provides a biologist-oriented resource for the analysis of systems- level datasets. Nat Commun, 2019, 10(1):1523.
[18] Conesa A, Nueda MJ, Ferrer A, Talón M. maSigPro: a method to identify significantly differential expression profiles in time-course microarray experiments. Bioinformatics, 2006, 22(9):1096-1102.
[19] Fontana RJ. Pathogenesis of idiosyncratic drug-induced liver injury and clinical perspectives. Gastroenterology, 2014, 146(4):914-928.
[20] Boelsterli UA, Lee KK. Mechanisms of isoniazid-induced idiosyncratic liver injury: Emerging role of mitochondrial stress. J Gastroenterol Hepatol, 2014, 29(4):678-687.
[21] Wiesel-Motiuk N, Assaraf YG. The key roles of the lysine acetyltransferases KAT6A and KAT6B in physiology and pathology. Drug Resist Updat, 2020, 53:100729.
[22] Jin Y, Yang RN, Ding JY, Zhu FQ, Zhu CL, Xu QG, Cai JZ. KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP. Biochem Biophys Res Commun, 2021, 585:185-190.
[23] Takeda T, Banno K, Okawa R, Yanokura M, Iijima M, Irie-Kunitomi H, Nakamura K, Iida M, Adachi M, Umene K, Nogami Y, Masuda K, Kobayashi Y, Tominaga E, Aoki D. ARID1A gene mutation in ovarian and endometrial cancers (Review). Oncol Rep, 2016, 35(2):607-613.
[24] Li WP, Yang LG, He Q, Hu CB, Zhu LY, Ma XL, Ma XY, Bao SJ, Li L, Chen YY, Deng X, Zhang X, Cen J, Zhang L, Wang Z, Xie WF, Li H, Li YX, Hui LJ. A homeostatic Arid1a-dependent permissive chromatin state licenses hepatocyte responsiveness to liver-injury-associated YAP signaling. Cell Stem Cell, 2019, 25(1): 54-68.e5.
[25] Mirman Z, de Lange T. 53BP1: a DSB escort. Genes Dev, 2020, 34(1-2):7-23.
[26] Shibata A, Jeggo PA. Roles for 53BP1 in the repair of radiation-induced DNA double strand breaks. DNA Repair (Amst), 2020, 93:102915.
[27] Tang XZ, Guo MJ, Ding PG, Deng ZD, Ke MY, Yuan YX, Zhou YY, Lin ZG, Li MX, Gu CY, Gu XS, Yang Y. BUB1B and circBUB1B_544aa aggravate multiple myeloma malignancy through evoking chromosomal instability. Signal Transduct Target Ther, 2021, 6(1):361.
[28] Xu MJ, Yao J, Shi YC, Yi HJ, Zhao WK, Lin XH, Yang ZZ. The SRCAP chromatin remodeling complex promotes oxidative metabolism during prenatal heart development. Development, 2021, 148(8): dev199026.
[29] Gopisetty G, Thangarajan R. Mammalian mitochondrial ribosomal small subunit (MRPS) genes: A putative role in human disease. Gene, 2016, 589(1):27-35.
文章导航

/